Back to RCUS
CITADEL ADVISORS LLC RCUS Position History
Arcus Biosciences, Inc. • Healthcare
Quarters held
7
Latest value
$839K
Q2 2026
Peak value
$96.7M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $28.7M |
| Q1 2026 | $1.7M |
| Q1 2026 | $216K |
| Q2 2026 | $96.7M |
| Q2 2026 | $839K |
| Q2 2026 | $96.7M |
| Q2 2026 | $839K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $839K | 27.2K | — | — |
| Q2 2026 | $96.7M | 3.14M | — | — |
| Q2 2026 | $839K | 27.2K | — | — |
| Q2 2026 | $96.7M | 3.14M | — | — |
| Q1 2026 | $216K | 10.0K | — | — |
| Q1 2026 | $1.7M | 80.5K | — | — |
| Q1 2026 | $28.7M | 1.33M | — | — |
Other funds holding RCUS
$185.9M
$185.9M
$116.9M
$100.3M
$80.7M